Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Veradermics, Incorporated Common Stock
(NY:
MANE
)
99.00
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Apr 30, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Veradermics, Incorporated Common Stock
Veradermics Announces Pricing of Upsized Public Offering and Private Placement
April 29, 2026
From
Veradermics, Incorporated
Via
Business Wire
Veradermics Announces Launch of Public Offering
April 27, 2026
From
Veradermics, Incorporated
Via
Business Wire
These stocks are moving in today's session
↗
April 27, 2026
Via
Chartmill
Top stock movements in today's session.
↗
April 27, 2026
Via
Chartmill
These stocks are gapping in today's session
↗
April 27, 2026
Via
Chartmill
Top movers in Monday's pre-market session
↗
April 27, 2026
Via
Chartmill
Veradermics’ Oral VDPHL01 Achieved Early, Consistent, and Robust Hair Growth in Positive Phase 2/3 ‘302’ Clinical Trial in Male Pattern Hair Loss
April 27, 2026
From
Veradermics, Inc.
Via
Business Wire
Veradermics to Hold Conference Call to Discuss Topline Results from Phase 2/3 ‘302’ Study of VDPHL01 in Males with Mild-to-Moderate Pattern Hair Loss
April 26, 2026
From
Veradermics, Incorporated
Via
Business Wire
Veradermics Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Corporate and Clinical Updates
March 30, 2026
From
Veradermics, Incorporated
Via
Business Wire
Veradermics Announces Presentations on VDPHL01 and Patient Experiences With Pattern Hair Loss at 2026 American Academy of Dermatology Annual Meeting
March 18, 2026
From
Veradermics, Incorporated
Via
Business Wire
Veradermics to Participate in Upcoming March Investor Conferences
March 03, 2026
From
Veradermics, Incorporated
Via
Business Wire
Veradermics Completes Enrollment in Second Pivotal Phase 3 Clinical Trial of VDPHL01 for Male Pattern Hair Loss
February 09, 2026
From
Veradermics, Incorporated
Via
Business Wire
Veradermics Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering
February 05, 2026
From
Veradermics, Incorporated
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.